TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer
By
Rene Jackstadt
Source
Nature CommunicationsTROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancernature.comYou might also wanna read
T cell-myeloid reprogramming overcomes immune resistance in colorectal cancer models
This article presents a scientific study on colorectal cancer (CRC) immunotherapy resistance. It shows that during anti-PD-1 treatment, tumo
Antibody-ligand motif optimization enables multitarget switchable CAR-T therapy against solid tumors
This article presents a research study on optimizing a multitarget switchable CAR-T (sCAR-T) strategy to overcome antigenic heterogeneity an
Targeting genomic instability: From chemotherapy to precision medicine in cancer treatment
This article examines genomic instability as a hallmark of cancer, explaining how it drives malignant transformation through accumulated gen
AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from
Combination therapy with RAS inhibitors shows promise for pancreatic cancer regression and resistance prevention
This research article presents a study on a targeted combination therapy for pancreatic ductal adenocarcinoma (PDAC), one of the deadliest c
pnas.org·24d ago
Antibody-Drug Conjugates in Perioperative Treatment of Muscle-Invasive Bladder Cancer: Expert Perspectives
This article discusses the emerging role of antibody-drug conjugates (ADCs) in the perioperative treatment of muscle-invasive bladder cancer
mdsc.pe·4d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.